# Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem

Study · id `cardio:ct-nct01408524` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01408524](<https://clinicaltrials.gov/study/NCT01408524>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01408524

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.

## Technical summary

Registry record NCT01408524. Randomized; quadruple masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2012-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 184 participants (enrolled count; ClinicalTrials.gov record NCT01408524, source copy `cardio:ctgov-nct01408524-2014-04-01`, retrieved 2026-10-26)
- Start date: 2010-02 (registry gives no type) (ClinicalTrials.gov record NCT01408524, source copy `cardio:ctgov-nct01408524-2014-04-01`, retrieved 2026-10-26)
- Primary completion: 2012-11 (actual) (ClinicalTrials.gov record NCT01408524, source copy `cardio:ctgov-nct01408524-2014-04-01`, retrieved 2026-10-26)
- Completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01408524, source copy `cardio:ctgov-nct01408524-2014-04-01`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01408524-2014-04-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem
- Condition: Hypertension
- Condition: Craniotomy
- Intervention (Drug): Diltiazem
- Intervention (Drug): Labetalol
- Lead sponsor: Mahidol University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Diltiazem (`cardio:diltiazem`)
- Registry lists this organization as the lead sponsor: Mahidol University (`cardio:org-mahidol-university`)

## Provenance

Content hash: b1fedbbff168eefd3e27de29cfc9dfacdb458d63eaccfdc9f996cfbffd2f7746
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
